IMO a significant possibility exists that PPHM Bavituximab has already been tried in humans with Ebola. Not trying it by this time seems incredible. Looking back,
"TUSTIN, CA, and ORLANDO, FL -- (MARKET WIRE) -- 11/17/10 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and viral infections, today announced preclinical data demonstrating its lead antibody bavituximab's ability to bind to virus particles and virus-infected cells of five viruses that cause viral hemorrhagic fever (VHF), including the highly lethal Ebola virus. Additionally, Peregrine reported bavituximab in combination with the antiviral drug ribavirin improved survival by up to 50% compared to either drug used as a monotherapy in several models of VHF. These data are being presented at the 2010 Chemical and Biological Defense Science and Technology Conference in Orlando, Florida."
It is far more likely in my mind that Bavi does not work in late stage Ebola than that Bavi has not been tried. I also think there is a significant chance that M_APP pharmaceuticals, manufacturer of "Z_M-APP" is a front for an agency that need not be named, and is primarily involved in M(onoclonal antibody) applications which might have APPlication in various fields of governmental interest.
News 
Market Data 
Discover 
